Claus Asbjørn Andersson

Claus Asbjørn Andersson was the founder of Equinostic ApS, founded in 2005, where the title held was Chairman from 2010 to 2012.
Current jobs include Chief Executive Officer at Sunstone LSV Invest III ApS, Sunstone LSV Special Limited Partner III Aps, Parsimoneous Holding ApS, Sunstone Tv Lsv Special LP Ill Aps, Sunstone LSV General Partner Ill ApS, Abinitio ApS, and Asbjørn Andersson ApS.
Director roles are held at JenaValve Technology GmbH, FBC Device ApS, Forendo Pharma Oy (since 2019), Sunstone LSV Management A, IO Biotech ApS, Acarix A (since 2010), ReWind Therapeutics NV (since 2023), Sunstone Lsv General Partner Ii ApS, and Lytix Biopharma AS (since 2025).
Other current positions include Partner at Life Science Ventures (since 2005), Owner at Sunstone LSV General Partner I ApS, Sunstone LSV General Partner BI ApS, and Latentix ApS, Member at The International Venture Club, General Partner at Sunstone Life Science Ventures A (since 2011), and Partner at Sunstone Capital A (since 2007).
Former jobs include Chief Executive Officer at Sunstone LSV Partners & Co. Holding III ApS, Sunstone LSV Partners Holding III ApS, Sunstone LSV Invest III Holding ApS, Sunstone LSV & Co. Special Limited Partner III Holding ApS, Sunstone Lsv Special Ltd. Partner Iii Holding Aps, and Sunstone Lsv & Co. Invest Ill Holding Aps.
Director roles were held at RICC A (2010–2014), PreciSense A, Jurag Separation ApS, Cantargia AB (2013–2021), Acarix AB (2010–2020), Aro Medical ApS, Follicum AB, and IO Biotech, Inc. (2016–2022).
Manager at Radiometer Medical ApS in 2001.
Education includes graduate degrees from Technical University of Denmark and the University of Copenhagen, and a doctorate from Humboldt-Universität zu Berlin.